Biologics Safety Testing | Detect contaminants like bacterial toxins, mycoplasma, and viruses

Biologics are pharmaceutical products that are extracted from biological sources The global biologics safety testing market is expected to reach USD 4.90 Billion by 2022 from USD 2.75 Billion in 2017, at a CAGR of 12.2% during forecast period.